|
|
Volumn 35, Issue 4, 2000, Pages 418-430
|
|
New drugs approved by the FDA; new dosage forms and indications; agents pending FDA approval; major labeling changes
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID PLUS DIPYRIDAMOLE;
ALOSETRON;
BEXAROTENE;
CEFPODOXIME PROXETIL;
CEVIMELINE;
CICLOPIROX;
CICLOPIROXOLAMINE;
DALFOPRISTIN PLUS QUINUPRISTIN;
DEXMEDETOMIDINE;
DOFETILIDE;
ENTACAPONE;
EPIRUBICIN;
ETIRACETAM;
EXEMESTANE;
FEXOFENADINE;
GADOVERSETAMIDE;
GATIFLOXACIN;
LEVOBUPIVACAINE;
LEVOFLOXACIN;
LUNG SURFACTANT EXTRACT;
MEQUINOL;
MEQUINOL PLUS RETINOIC ACID;
MOXIFLOXACIN;
NEW DRUG;
NITRIC OXIDE;
OXCARBAZEPINE;
PANTOPRAZOLE;
PEMIROLAST;
PERINDOPRIL;
RABEPRAZOLE;
RAPACURONIUM BROMIDE;
RAPAMYCIN;
TEMOZOLOMIDE;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
ZALEPLON;
DRUG APPROVAL;
DRUG CLASSIFICATION;
DRUG DOSAGE FORM;
DRUG INDICATION;
DRUG LABELING;
DRUG SAFETY;
FOOD AND DRUG ADMINISTRATION;
REVIEW;
|
|
EID: 0034117154
PISSN: 00185787
EISSN: None
Source Type: Journal
DOI: 10.1177/001857870003500405 Document Type: Review |
|
Times cited : (1)
|
|
References (0)
|
